Phase I/II study of oral fluoropyrimidine S-1 plus oral Leucovorin as first-line treatment for metastatic colorectal cancer

被引：0
|
作者：
Yoshino, T.
Koizumi, W.
Yamaguchi, K.
Miyata, Y.
Kato, T.
Toh, Y.
Sawaki, A.
Hyodo, I.
Nishina, T.
Boku, N.
机构：
[1] Shizuoka Canc Ctr, Shizuoka, Japan
[2] Kitasato Univ, East Hosp, Sagamihara, Kanagawa, Japan
[3] Saitama Canc Ctr, Saitama, Japan
[4] Saku Cent Hosp, Nagano, Japan
[5] Minoh City Hosp, Osaka, Japan
[6] Natl Kyushu Canc Ctr, Fukuoka, Fukuoka, Japan
[7] Aichi Canc Ctr, Nagoya, Aichi, Japan
[8] Univ Tsukuba, Tsukuba, Ibaraki, Japan
[9] NHO Shikoku Canc Ctr, Matsuyama, Ehime, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4093
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I study of oral fluoropyrimidine S-1 plus oral leucovorin in patients with metastatic colorectal cancer
    Hyodo, Ichinosuke
    Nishina, Tomohiro
    Boku, Narikazu
    Yoshino, Takayuki
    Narahara, Hiroyuki
    Sugimoto, Naotoshi
    ANNALS OF ONCOLOGY, 2006, 17 : 120 - 121
  • [2] Phase I/II study of novel oral fluoropyrimidine S-1 in combination with oxaliplatin (SOX) as first-line chemotherapy for metastatic colorectal cancer (mCRC)
    Tahara, M.
    Yamada, Y.
    Ohtsu, A.
    Shirao, K.
    Shimada, Y.
    Sasaki, Y.
    Yamamoto, W.
    Satoh, T.
    Okamoto, W.
    Tanigawara, Y.
    EJC SUPPLEMENTS, 2007, 5 (04): : 254 - 254
  • [3] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
    Yamada, Y.
    Tahara, M.
    Miya, T.
    Satoh, T.
    Shirao, K.
    Shimada, Y.
    Ohtsu, A.
    Sasaki, Y.
    Tanigawara, Y.
    BRITISH JOURNAL OF CANCER, 2008, 98 (06) : 1034 - 1038
  • [4] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
    Y Yamada
    M Tahara
    T Miya
    T Satoh
    K Shirao
    Y Shimada
    A Ohtsu
    Y Sasaki
    Y Tanigawara
    British Journal of Cancer, 2008, 98 : 1034 - 1038
  • [5] Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer
    Yoshino, Takayuki
    Hyodo, Ichinosuke
    Nishina, Tomohiro
    Narahara, Hiroyuki
    Sugimoto, Naotoshi
    Yoshisue, Kunihiro
    Boku, Narikazu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 107 - 116
  • [6] A Phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients
    Hsu, Hung-Chih
    Chou, Wen-Chi
    Kuan, Feng-Che
    Lee, Kuan-Der
    Rau, Kun-Ming
    Huang, En-Seng
    Yang, Tsai-Sheng
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6061 - 6070
  • [7] Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer
    Takayuki Yoshino
    Ichinosuke Hyodo
    Tomohiro Nishina
    Hiroyuki Narahara
    Naotoshi Sugimoto
    Kunihiro Yoshisue
    Narikazu Boku
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 107 - 116
  • [8] Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer
    Yasuhide Yamada
    Tatsuro Yamaguchi
    Hiroshi Matsumoto
    Yasushi Ichikawa
    Ayumu Goto
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhiro Shimada
    Investigational New Drugs, 2012, 30 : 1690 - 1696
  • [9] Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer
    Yamada, Yasuhide
    Yamaguchi, Tatsuro
    Matsumoto, Hiroshi
    Ichikawa, Yasushi
    Goto, Ayumu
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1690 - 1696
  • [10] Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
    Koizumi, W.
    Boku, N.
    Yamaguchi, K.
    Miyata, Y.
    Sawaki, A.
    Kato, T.
    Toh, Y.
    Hyodo, I.
    Nishina, T.
    Furuhata, T.
    Miyashita, K.
    Okada, Y.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 766 - 771
12345